Gastric Cancer Connect
  • Saved
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer

p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer

Source : https://www.sciencedirect.com/science/article/abs/pii/S0006295220305566?via=ihub

Cell cycle control is often disrupted in gastric cancer (GC), making it an attractive therapeutic target. Abemaciclib is a specific CDK4/6 inhibitor that has been shown to improve treatment efficacy...


Relevance: Cell cycle control is often disrupted in gastric cancer (GC), making it an attractive therapeutic target. Abemaciclib is a specific CDK4/6 inhibitor that has been shown to improve treatment efficacy in hormone receptor-positive advanced breast cancer; however, its potential therapeutic value and predictive markers have not yet been...

  • Saved
Establishment and characterization of adult human gastric epithelial progenitor-like cell lines - PubMed

Establishment and characterization of adult human gastric epithelial progenitor-like cell lines - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36331058/

Our culture system of hGEPL cells from adults is robust and easy to operate, and has the transformative potential of personalized and precision medicine, laying a solid foundation for studying...


Conclusions: Our culture system of hGEPL cells from adults is robust and easy to operate, and has the transformative potential of personalized and precision medicine, laying a solid foundation for studying the self-renewal and differentiation potentials of gastric epithelial stem/progenitor cells as well as modelling of related gastric diseases.

  • Saved
Successful outcome of neoadjuvant PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy for potentially unresectable esophagogastric junctional squamous cell carcinoma: a case report

Successful outcome of neoadjuvant PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy for potentially unresectable esophagogastric junctional squamous cell carcinoma: a case report

Source : https://tcr.amegroups.com/article/view/66878/html

Gastric squamous cell carcinoma (SCC) is a rare malignancy, its incidence is less than 2% among all gastric cancers, and esophagogastric junctional SCC (EJSCC) occupies over 80% ( 1). The...


Conclusions: PD-1 blockade, VEGFR-2 inhibitor plus chemotherapy is effective and safe for the patient with EJSCC.


  • Saved
Health Benefits and Pharmacological Properties of Stigmasterol - PubMed

Health Benefits and Pharmacological Properties of Stigmasterol - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36290632/

Stigmasterol is an unsaturated phytosterol belonging to the class of tetracyclic triterpenes. It is one of the most common plant sterols, found in a variety of natural sources, including vegetable...


Conclusions: This review outlines key insights into the pharmacological abilities of stigmasterol and the specific mechanisms of action underlying some of these effects. Additionally, further investigation regarding pharmacodynamics, pharmacokinetics, and toxicology is recommended.


  • Saved
Targeting FGFR2 positive gastroesophageal cancer | OTT

Targeting FGFR2 positive gastroesophageal cancer | OTT

Source : https://www.dovepress.com/targeting-fgfr2-positive-gastroesophageal-cancer-current-and-clinical--peer-reviewed-fulltext-article-OTT

Gastroesophageal cancer encompasses three major subdivisions which are histologically, epidemiologically, and pathologically different: gastric adenocarcinoma, gastroesophageal junctional (GEJ) adenocarcinoma and oesophageal cancer, which is further classified into squamous cell carcinoma...


Relevance: In our review, we outline the FGFR pathway and focus on the developments and challenges of targeting FGFR2 driven gastroesophageal cancers.